Free Trial
→ You’re Being LIED To About The Iran War (From Banyan Hill Publishing) (Ad)tc pixel Free FATE Stock Alerts

Fate Therapeutics (FATE) Earnings Date, Estimates & Call Transcripts

Fate Therapeutics logo
$2.36 +0.56 (+31.11%)
Closing price 04:00 PM Eastern
Extended Trading
$2.38 +0.02 (+0.64%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Fate Therapeutics Earnings Summary

Fate Therapeutics issued Q4 2025 earnings on February 26, 2026, reporting an EPS of -$0.27, which met analysts' consensus estimates of -$0.27. Quarterly revenue was reported to be $1.37 million, above analyst estimates of $1.20 million. With a trailing EPS of -$1.15, Fate Therapeutics' earnings are expected to grow next year, from ($1.10) to ($1.02) per share.

Upcoming
Earnings Date
May. 12Before Market OpensEstimated
Consensus EPS
(Feb. 26)
-$0.27
Actual EPS
(Feb. 26)
-$0.27
Actual Revenue
(Feb. 26)
$1.37M

Q4 2025 Earnings Resources

FATE Upcoming Earnings

Fate Therapeutics' Q1 2026 earnings is estimated for Tuesday, May 12, 2026, based on past reporting schedules, with a conference call scheduled on Thursday, May 14, 2026 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Powered by Quartr
Get Fate Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fate Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

FATE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

FATE Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Fate Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.34-$0.34-$0.34
Q2 20261-$0.35-$0.35-$0.35
Q3 20262-$0.32-$0.29-$0.31
Q4 20262-$0.33-$0.30-$0.32

Fate Therapeutics Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/12/2026
(Estimated)		--------
2/26/2026Q4 2025-$0.27-$0.27--$0.27$1.20M$1.37M
11/13/2025Q3 2025-$0.29-$0.27+$0.02-$0.27$1.63M$1.74M
8/12/2025Q2 2025-$0.35-$0.29+$0.06-$0.29$1.16M$1.91M
5/13/2025Q1 2025-$0.39-$0.32+$0.07-$0.32$1.18M$1.63M
3/5/2025Q4 2024-$0.44-$0.31+$0.13-$0.44$1.57M$1.86M
11/12/2024--$0.42-$0.40+$0.02-$0.40$0.88M$3.07M
8/13/2024--$0.47-$0.33+$0.14-$0.33$1.47M$6.77M
5/9/2024Q1 2024-$0.47-$0.47--$0.47$0.80M$1.93M

Data powered by Fiscal.ai.

Fate Therapeutics Earnings - Frequently Asked Questions

Fate Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 12th, 2026 based off last year's report dates. Learn more on FATE's earnings history.

In the previous quarter, Fate Therapeutics (NASDAQ:FATE) reported ($0.27) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.27). Learn more on analysts' earnings estimate vs. FATE's actual earnings.

Fate Therapeutics (NASDAQ:FATE) has a recorded annual revenue of $6.65 million.

Fate Therapeutics (NASDAQ:FATE) has a recorded net income of -$136.32 million. FATE has generated -$1.15 earnings per share over the last four quarters.

Fate Therapeutics' earnings are expected to grow from ($1.10) per share to ($1.02) per share in the next year.

Related Companies
Earnings Tools

This page (NASDAQ:FATE) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel
Invest in SpaceX Before IPO
SpaceX is already one of the most valuable private companies on Earth, and some analysts believe its valuation...
NXT Wave Research | Sponsoredtc pixel
URGENT: $2 Gold Stock With Major Discovery
A $2 gold stock is said to quietly control what may be the largest gold deposit in the world - worth nearly $1...
Paradigm Press | Sponsoredtc pixel